Slide 1: Fireside Chat
Exhibit 99.1 Fireside Chat Keith Sullivan President & CEO, Neuronetics, Inc. Bill Leonard President & CEO, Greenbrook TMS
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains estimates and other statistical data prepared by independent parties and by Neuronetics, Inc. (the “Company”) relating to market size and growth and other data about the industry in which the Company operates. These estimates and data involve a n
Slide 3: No Offer or Solicitation
No Offer or Solicitation This communication is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities,
Slide 4: Fireside Chat
Fireside Chat Keith Sullivan President & CEO, Neuronetics, Inc. Bill Leonard President & CEO, Greenbrook TMS
Slide 5: You had a LOT of Questions!
You had a LOT of Questions! How will acquisition help my individual practice? What will happen to the Greenbrook brand name? Company Confidential 5
Slide 6: Question Themes
Question Themes Is NeuroStar now going to be competing with me? How will NeuroStar’s marketing strategy change? How will acquisition help my individual practice? Company Confidential 6
Slide 7: Focused on Practice Success
Focused on Practice Success PHQ-10 NeuroStar University Company Confidential 7
Slide 8: Some Stats You May Not Know
Some Stats You May Not Know Between 2008 and 2019 2.8M Treatments 12 Years Between 2020 and 2023 3.6M Treatments 3 Years Between 2008 and 2019 80,359 Patients 12 Years Between 2020 and 2023 88,533 Patients 3 Years Company Confidential
Slide 9: Advantages of Greenbrook Acquisition
Advantages of Greenbrook Acquisition Knowledge Patient Access to and Best Lifecycle Services Practices Management Company Confidential 9
Slide 10: Amplifying Brand Awareness
Amplifying Brand Awareness Company Confidential 10
Slide 11: Starbucks Coffee
STARBUCKS COFFE
Slide 12: 12
12
Slide 13: Ori Adv eas
Ori Adv eas z i oT i “F f= f = i “= “ = = ¢ Company Confidential 13
Slide 14: You can feel better with Greenbrook TMS therapy
You can feel better WITH GREENBROOK TMS THERAPY FOR MDD AND OCD. VV FDA-Approved Spravato®* V FDA-Cleared TMS** V Medication Management* ¥ Talk Therapy* V Covered by most major insurances ‘only ofered at select location ‘stranseanial Magnetic Stimulation therapy Company Confidential
Slide 15: Here for you
HERE FOR YOU TOUGHEST DAYS. Call today for a new wa} to fight depression. 866-984-5577 we] tw way Ya | i —_ mn lYESTERDAY YOu SAID TOMORROW. can be BEAT / @ _ 266-984-5577
Slide 16: Patients Select a Provider of Choice
Patients that go to NeuroStar.com’s Provider Locator Patients Select a Provider of Choice ŒŽ Former NeuroStar Provider Locator Patients CHOOSE a Provider Greenbrook Ad Budget Company Confidential 16
Slide 17: Amplifying Brand Awareness
Amplifying Brand Awareness What this means to you is that the current NeuroStar inside your practice BECOMES EVEN MORE RECOGNIZABLE TO PATIENTS Company Confidential 17
Slide 18: Biggest challenges for NeuroStar Practices
What are the biggest challenges for NeuroStar Practices? Reimbursement Billing Contracts Cash Flow Call center Company Confidential 18
Slide 19: Beyond Brand Awareness, what's in it for NeuroStar Practices?
Beyond Brand Awareness, what’s in it for NeuroStar Practices? National and regional payer contracts Insurance billing services Increased Service Centralized Call center Offerings Referral networks New training: how to incorporate med management, Spravato Company Confidential 19
Slide 20: NeuroStar Fireside Chat Transcript
Q&A Exhibit 99.2 NeuroStar Fireside Chat Transcript Marjorie Donovan Head of Customer Education Keith Sullivan President & CEO, Neuronetics, Inc. Bill Leonard President & CEO, Greenbrook TMS Marjorie Donovan Head of Customer Education Good afternoon, and welcome to the NeuroStar Fireside Chat. We ar